Glaukos Management
Management criteria checks 4/4
Glaukos' CEO is Tom Burns, appointed in Apr 2002, has a tenure of 22.08 years. total yearly compensation is $6.27M, comprised of 11.6% salary and 88.4% bonuses, including company stock and options. directly owns 2.98% of the company’s shares, worth $142.13M. The average tenure of the management team and the board of directors is 2.8 years and 9.8 years respectively.
Key information
Tom Burns
Chief executive officer
US$6.3m
Total compensation
| CEO salary percentage | 11.6% |
| CEO tenure | 22yrs |
| CEO ownership | 3.0% |
| Management average tenure | 2.8yrs |
| Board average tenure | 9.8yrs |
Recent management updates
Recent updates
Glaukos Corporation (NYSE:GKOS) Not Lagging Industry On Growth Or Pricing
Apr 04
Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 69% Above Its Share Price
Feb 21Is Glaukos (NYSE:GKOS) A Risky Investment?
Jan 21Glaukos: Remains A Hold Due To High Valuation And Negative Profitability
Jan 09Glaukos Corporation's (NYSE:GKOS) 27% Jump Shows Its Popularity With Investors
Dec 20Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Nov 03Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Oct 05Glaukos: Continued Growth Rates, Regulatory Tailwinds, And Support
Sep 01Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Glaukos: Revising To Buy On These 3 Catalytic Factors
Jun 16Risks To Shareholder Returns Are Elevated At These Prices For Glaukos Corporation (NYSE:GKOS)
Apr 19Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Feb 19Glaukos: Trial Momentum Building, Profitability Differentials Yet To Pull Through
Feb 14Glaukos sees positive data from mid-stage trial of dry eye treatment
Jan 10Glaukos: Show Me The Money
Nov 10Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Oct 16Glaukos pays $10M upfront to license iVeena's eye disorder therapy IVMED-80
Aug 24Glaukos: Gross Margins Compressing Despite FY22 Guidance Revision
Aug 04Glaukos gains as Stifel upgrades to Buy citing 2022 sales upside
Jul 12Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Mar 14Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Nov 29Is Glaukos (NYSE:GKOS) Weighed On By Its Debt Load?
Aug 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$135m |
| Sep 30 2023 | n/a | n/a | -US$129m |
| Jun 30 2023 | n/a | n/a | -US$126m |
| Mar 31 2023 | n/a | n/a | -US$139m |
| Dec 31 2022 | US$6m | US$730k | -US$99m |
| Sep 30 2022 | n/a | n/a | -US$90m |
| Jun 30 2022 | n/a | n/a | -US$56m |
| Mar 31 2022 | n/a | n/a | -US$28m |
| Dec 31 2021 | US$7m | US$702k | -US$50m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$83m |
| Dec 31 2020 | US$6m | US$608k | -US$120m |
| Sep 30 2020 | n/a | n/a | -US$73m |
| Jun 30 2020 | n/a | n/a | -US$71m |
| Mar 31 2020 | n/a | n/a | -US$37m |
| Dec 31 2019 | US$6m | US$644k | US$15m |
| Sep 30 2019 | n/a | n/a | -US$19m |
| Jun 30 2019 | n/a | n/a | -US$12m |
| Mar 31 2019 | n/a | n/a | -US$12m |
| Dec 31 2018 | US$5m | US$625k | -US$13m |
| Sep 30 2018 | n/a | n/a | -US$14m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$4m |
| Dec 31 2017 | US$5m | US$600k | -US$92k |
Compensation vs Market: Tom's total compensation ($USD6.27M) is about average for companies of similar size in the US market ($USD6.64M).
Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.
CEO
Tom Burns (62 yo)
22yrs
Tenure
US$6,268,188
Compensation
Mr. Thomas William Burns, also known as Tom, has been the Chief Executive Officer at Glaukos Corporation since April 1, 2022 and serves as its Chairman of the Board since December 31, 2021. He had Presiden...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 22yrs | US$6.27m | 2.98% $ 142.1m | |
| President & COO | 2yrs | US$6.97m | 0.051% $ 2.5m | |
| Senior VP & CFO | 2yrs | US$2.13m | 0.048% $ 2.3m | |
| Executive Vice President of Global Commercial Operations | 2yrs | US$198.66k | 0.34% $ 16.4m | |
| Chief Development Officer | 3.5yrs | US$2.42m | 0.051% $ 2.4m | |
| Co-Founder | no data | no data | no data | |
| Vice President of Investor Relations & Corporate Affairs | no data | no data | no data | |
| VP of Compliance & Deputy General Counsel | no data | no data | no data | |
| Senior Vice President of Human Resources | 8.9yrs | no data | no data | |
| Senior Vice President of Corporate Strategy & Business Development | 6yrs | no data | no data | |
| Senior Vice President of Governance | less than a year | no data | no data |
2.8yrs
Average Tenure
60yo
Average Age
Experienced Management: GKOS's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 22.1yrs | US$6.27m | 2.98% $ 142.1m | |
| Independent Director | 4.1yrs | US$250.01k | 0.054% $ 2.6m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 9.8yrs | US$259.01k | 0.062% $ 2.9m | |
| Lead Independent Director | 9.8yrs | US$307.90k | 0.061% $ 2.9m | |
| Independent Director | 9.8yrs | US$259.01k | 0.074% $ 3.5m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 9.8yrs | US$273.37k | 0.065% $ 3.1m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
9.8yrs
Average Tenure
60yo
Average Age
Experienced Board: GKOS's board of directors are considered experienced (9.8 years average tenure).